Complete genome sequence of hypervirulent and outbreak-associated Acinetobacter baumannii strain LAC-4: Epidemiology, resistance genetic determinants and potential virulence factors

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Ou, Hong Yu ^a   Kuang, Shan N ^b   He, Xinyi ^a   Molgora, Brenda M ^b   Ewing, Peter J ^b   Deng, Zixin ^a   Osby, Melanie ^c,e   Chen, Wangxue ^d   Xu, H Howard ^b  

^a Shanghai Jiao Tong University   (China)

^b CALIFORNIA STATE UNIVERSITY   (United States)

^c LAC USC MEDICAL CENTER   (United States)

^d NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^e Outpatient Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSPOSON; VIRULENCE FACTOR;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTIBIOTIC RESISTANCE; BACTERIAL CHROMOSOME; BACTERIAL GENOME; CLASSIFICATION; COMPUTER SIMULATION; DNA SEQUENCE; EPIDEMIC; GENE EXPRESSION REGULATION; GENE LOCUS; GENETICS; GENOMIC ISLAND; GENOMICS; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOLECULAR GENETICS; MULTIDRUG RESISTANCE; MULTILOCUS SEQUENCE TYPING; NUCLEOTIDE SEQUENCE; PATHOGENICITY; PHYLOGENY; POLYMERASE CHAIN REACTION; TRANSPOSON; UNITED STATES; VIRULENCE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; BASE SEQUENCE; CHROMOSOMES, BACTERIAL; COMPUTER SIMULATION; DISEASE OUTBREAKS; DNA TRANSPOSABLE ELEMENTS; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; GENETIC LOCI; GENOME, BACTERIAL; GENOMIC ISLANDS; GENOMICS; HUMANS; LOS ANGELES; MOLECULAR SEQUENCE DATA; MULTILOCUS SEQUENCE TYPING; MUTAGENESIS, INSERTIONAL; PHYLOGENY; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; VIRULENCE; VIRULENCE FACTORS;

EID: 84923933160     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep08643     Document Type: Article

References (89)

1. Boucher, H. W. et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 48, 1-12 (2009).
2. Azim, A. et al. Epidemiology of bacterial colonization at ICU admission with emphasis on extended-spectrum beta-lactamases (ESBL) and metallo-beta-lactamase (MBL) producing gram-negative bacteria - an Indian experience. JMed Microbiol 59, 955-60 (2010).
3. Karlowsky, J. A. et al. Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001. Antimicrob Agents Chemother 47, 1681-8 (2003).
4. Sievert, D. M. et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. Infect Control Hosp Epidemiol 34, 1-14 (2013).
5. Valentine, S. C. et al. Phenotypic and molecular characterization of Acinetobacter baumannii clinical isolates from nosocomial outbreaks in Los Angeles County, California. J Clin Microbiol 46, 2499-507 (2008).
6. Huang, X. Z. et al. Molecular analysis of imipenem-resistant Acinetobacter baumannii isolated from US service members wounded in Iraq, 2003-2008. Epidemiol Infect 140, 2302-7 (2012).
7. Taitt, C. R. et al. Antimicrobial resistance determinants in Acinetobacter baumannii isolates taken from military treatment facilities. Antimicrob Agents Chemother 58, 767-81 (2014).
8. Antunes, L. C., Visca, P. & Towner, K. J. Acinetobacter baumannii: evolution of a global pathogen. Pathog Dis 71, 292-31 (2013).
9. Zarrilli, R., Pournaras, S., Giannouli, M. & Tsakris, A. Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages. Int J Antimicrob Agents 41, 11-9 (2013).
10. Poirel, L., Bonnin, R. A. & Nordmann, P. Genetic basis of antibiotic resistance in pathogenic Acinetobacter species. IUBMB Life 63, 1061-7 (2011).
11. Imperi, F. et al. The genomics of Acinetobacter baumannii: insights into genome plasticity, antimicrobial resistance and pathogenicity. IUBMB Life 63, 1068-74 (2011).
12. Mosqueda, N. et al. Globally expanding carbapenemase finally appears in Spain: nosocomial outbreak of acinetobacter baumannii producing plasmid-encoded OXA-23 in Barcelona, Spain. Antimicrob Agents Chemother 57, 5155-7 (2013).
13. Mugnier, P. D., Poirel, L., Naas, T. & Nordmann, P. Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii. Emerg Infect Dis 16, 35-40 (2010).
14. Bou, G., Oliver, A. & Martinez-Beltran, J. OXA-24, a novel class D beta-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain. Antimicrob Agents Chemother 44, 1556-61 (2000).
15. Grosso, F., Quinteira, S., Poirel, L., Novais, A. & Peixe, L. Role of common blaOXA-24/OXA-40-carrying platforms and plasmids in the spread of OXA-24/OXA-40 among Acinetobacter species clinical isolates. Antimicrob Agents Chemother 56, 3969-72 (2012).
16. Metan, G., Sariguzel, F., Sumerkan, B., Reijden, T. & Dijkshoorn, L. Clonal diversity and high prevalence of OXA-58 among Acinetobacter baumannii isolates from blood cultures in a tertiary care centre in Turkey. Infect Genet Evol 14, 92-7 (2013).
17. Zhu, L. et al. Complete genome analysis of three Acinetobacter baumannii clinical isolates in China for insight into the diversification of drug resistance elements. PLoS One 8, e66584 (2013).
18. Adams, M. D. et al. Comparative genome sequence analysis of multidrug-resistant Acinetobacter baumannii. J Bacteriol 190, 8053-64 (2008).
19. Smith, M. G. et al. New insights into Acinetobacter baumannii pathogenesis revealed by high-density pyrosequencing and transposon mutagenesis. Genes Dev 21, 601-14 (2007).
20. Park, J. Y. et al. Complete genome sequence of multidrug-resistant Acinetobacter baumannii strain 1656-2, which forms sturdy biofilm. J Bacteriol 193, 6393-4 (2011).
21. Iacono, M. et al. Whole-genome pyrosequencing of an epidemic multidrug-resistant Acinetobacter baumannii strain belonging to the European clone II group. Antimicrob Agents Chemother 52, 2616-25 (2008).
22. Vallenet, D. et al. Comparative analysis of Acinetobacters: three genomes for three lifestyles. PLoS One 3, e1805 (2008).
23. Farrugia, D. N. et al. The complete genome and phenome of a community-acquired Acinetobacter baumannii. PLoS One 8, e58628 (2013).
24. Gao, F. et al. Genome sequence of Acinetobacter baumannii MDR-TJ. J Bacteriol 193, 2365-6 (2011).
25. Zhou, H. et al. Genomic analysis of the multidrug-resistant Acinetobacter baumannii strain MDR-ZJ06 widely spread in China. Antimicrob Agents Chemother 55, 4506-12 (2011).
26. Chen, C. C. et al. Genome sequence of a dominant, multidrug-resistant Acinetobacter baumannii strain, TCDC-AB0715. J Bacteriol 193, 2361-2 (2011).
27. Liou, M. L. et al. Genome sequence of Acinetobacter baumannii TYTH-1. J Bacteriol 194, 6974 (2012).
28. Loewen, P. C., Alsaadi, Y., Fernando, D. & Kumar, A. Genome Sequence of a Tigecycline-Resistant Clinical Isolate of Acinetobacter baumannii Strain AB031 Obtained from a Bloodstream Infection. Genome Announc 2, e01036 (2014).
29. Loewen, P. C., Alsaadi, Y., Fernando, D. & Kumar, A. Genome Sequence of an Extremely Drug-Resistant Clinical Isolate of Acinetobacter baumannii Strain AB030. Genome Announc 2, e01035 (2014).
30. Merino, M. et al. Complete Genome Sequence of the Multiresistant Acinetobacter baumannii Strain AbH12O-A2, Isolated during a Large Outbreak in Spain. Genome Announc 2, e01182 (2014).
31. Sahl, J. W. et al. Evolution of a pathogen: a comparative genomics analysis identifies a genetic pathway to pathogenesis in Acinetobacter. PLoS One 8, e54287 (2013).
32. Wright, M. S. et al. New insights into dissemination and variation of the health care-associated pathogen Acinetobacter baumannii from genomic analysis. MBio 5, e00963-13 (2014).
33. Harris, G. et al. A mouse model of Acinetobacter baumannii - associated pneumonia using a clinically isolated hypervirulent strain. Antimicrob Agents Chemother 57, 3601-13 (2013).
34. Fournier, P. E. et al. Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS Genet 2, e7 (2006).
35. de Leseleuc, L., Harris, G., Kuolee, R., Xu, H. H. & Chen, W. Serum resistance, gallium nitrate tolerance and extrapulmonary dissemination are linked to heme consumption in a bacteremic strain of Acinetobacter baumannii. Int J Med Microbiol 304, 360-9 (2013).
36. Vinogradov, E., Maclean, L., Xu, H. H. & Chen, W. The structure of the polysaccharide isolated from Acinetobacter baumannii strain LAC-4. Carbohydr Res 390, 42-45 (2014).
37. Ahmed-Bentley, J. et al. Gram-negative bacteria that produce carbapenemases causing death attributed to recent foreign hospitalization. Antimicrob Agents Chemother 57, 3085-91 (2013).
38. Dijkshoorn, L. et al. Correlation of typing methods for Acinetobacter isolates from hospital outbreaks. J Clin Microbiol 31, 702-5 (1993).
39. Poirel, L., Menuteau, O., Agoli, N., Cattoen, C. & Nordmann, P. Outbreak of extended-spectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital. J Clin Microbiol 41, 3542-7 (2003).
40. Gogou, V. et al. Evolution of multidrug-resistant Acinetobacter baumannii clonal lineages: a 10 year study in Greece (2000-09). J Antimicrob Chemother 66, 2767-72 (2011).
41. Longo, B. et al. An outbreak of Acinetobacter baumannii in an intensive care unit: epidemiological and molecular findings. J Hosp Infect 64, 303-5 (2006).
42. Bertini, A. et al. Characterization and PCR-based replicon typing of resistance plasmids in Acinetobacter baumannii. Antimicrob Agents Chemother 54, 4168-77 (2010).
43. Chattoraj, D. K. Control of plasmid DNA replication by iterons: no longer paradoxical. Mol Microbiol 37, 467-76 (2000).
44. Segal, H. & Elisha, B. G. Characterization of the Acinetobacter plasmid, pRAY, and the identification of regulatory sequences upstream of an aadB gene cassette on this plasmid. Plasmid 42, 60-6 (1999).
45. Hamidian, M., Nigro, S. J. & Hall, R. M. Variants of the gentamicin and tobramycin resistance plasmid pRAY are widely distributed in Acinetobacter. J Antimicrob Chemother 67, 2833-6 (2012).
46. Wang, S. et al. Transcriptomic response of Escherichia coli O157:H7 to oxidative stress. Appl Environ Microbiol 75, 6110-23 (2009).
47. Huang, H. et al. Complete genome sequence of Acinetobacter baumannii MDR-TJ and insights into its mechanism of antibiotic resistance. J Antimicrob Chemother 67, 2825-32 (2012).
48. Heritier, C., Poirel, L. & Nordmann, P. Cephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumannii. Clin Microbiol Infect 12, 123-30 (2006).
49. Ramirez, M. S. & Tolmasky, M. E. Aminoglycoside modifying enzymes. Drug Resist Updat 13, 151-71 (2010).
50. Intorne, A. C., de Oliveira, M. V., de, M. P. L. & de Souza Filho, G. A. Essential role of the czc determinant for cadmium, cobalt and zinc resistance in Gluconacetobacter diazotrophicus PAl 5. Int Microbiol 15, 69-78 (2012).
51. Valencia, E. Y., Braz, V. S., Guzzo, C. & Marques, M. V. Two RND proteins involved in heavy metal efflux in Caulobacter crescentus belong to separate clusters within proteobacteria. BMC Microbiol 13, 79 (2013).
52. Vila, J., Marti, S. & Sanchez-Cespedes, J. Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii. J Antimicrob Chemother 59, 1210-5 (2007).
53. Coyne, S., Courvalin, P. & Perichon, B. Efflux-mediated antibiotic resistance in Acinetobacter spp. Antimicrob Agents Chemother 55, 947-53 (2011).
54. Coyne, S., Rosenfeld, N., Lambert, T., Courvalin, P. & Perichon, B. Overexpression of resistance-nodulation-cell division pump AdeFGH confers multidrug resistance in Acinetobacter baumannii. Antimicrob Agents Chemother 54, 4389-93 (2010).
55. Hornsey, M. et al. AdeABC-mediated efflux and tigecycline MICs for epidemic clones of Acinetobacter baumannii. J Antimicrob Chemother 65, 1589-93 (2010).
56. Hou, P. F., Chen, X. Y., Yan, G. F., Wang, Y. P. & Ying, C. M. Study of the correlation of imipenem resistance with efflux pumps AdeABC, AdeIJK, AdeDE and AbeM in clinical isolates of Acinetobacter baumannii. Chemotherapy 58, 152-8 (2012).
57. Marchand, I., Damier-Piolle, L., Courvalin, P. & Lambert, T. Expression of the RND-type efflux pump AdeABC in Acinetobacter baumannii is regulated by the AdeRS two-component system. Antimicrob Agents Chemother 48, 3298-304 (2004).
58. Yoon, E. J., Courvalin, P. & Grillot-Courvalin, C. RND-type efflux pumps in multidrug-resistant clinical isolates of Acinetobacter baumannii: major role for AdeABC overexpression and AdeRS mutations. Antimicrob Agents Chemother 57, 2989-95 (2013).
59. Sun, J. R. et al. A truncated AdeS kinase protein generated by ISAba1 insertion correlates with tigecycline resistance in Acinetobacter baumannii. PLoS One 7, e49534 (2012).
60. Rosenfeld, N., Bouchier, C., Courvalin, P. & Perichon, B. Expression of the resistance-nodulation-cell division pump AdeIJK in Acinetobacter baumannii is regulated by AdeN, a TetR-type regulator. Antimicrob Agents Chemother 56, 2504-10 (2012).
61. Russo, T. A. et al. The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor. Infect Immun 78, 3993-4000 (2010).
62. Haseley, S. R. & Wilkinson, S. G. Structural studies of the putative O-specific polysaccharide of Acinetobacter baumannii O24 containing 5,7-diamino-3,5,7,9-tetradeoxy-L-glycero-D-galacto-nonulosonic acid. Eur J Biochem 250, 617-23 (1997).
63. Hu, D., Liu, B., Dijkshoorn, L., Wang, L. & Reeves, P. R. Diversity in the major polysaccharide antigen of Acinetobacter baumannii assessed by DNA sequencing, and development of a molecular serotyping scheme. PLoS One 8, e70329 (2013).
64. Morrison, M. J. & Imperiali, B. The renaissance of bacillosamine and its derivatives: pathway characterization and implications in pathogenicity. Biochemistry 53, 624-38 (2014).
65. Post, D. M. et al. O-antigen and core carbohydrate of Vibrio fischeri lipopolysaccharide: composition and analysis of their role in Euprymna scolopes light organ colonization. J Biol Chem 287, 8515-30 (2012).
66. Tsvetkov, Y. E., Shashkov, A. S., Knirel, Y. A. & Zahringer, U. Synthesis and identification in bacterial lipopolysaccharides of 5,7-diacetamido-3,5,7,9-tetradeoxy-D-glycero-D-galacto- and -D-glycero-D-talo-non-2-ulosonic acids. Carbohydr Res 331, 233-7 (2001).
67. Haley, K. P. & Skaar, E. P. A battle for iron: host sequestration and Staphylococcus aureus acquisition. Microbes Infect 14, 217-27 (2012).
68. Wilks, A. & Burkhard, K. A. Heme and virulence: how bacterial pathogens regulate, transport and utilize heme. Nat Prod Rep 24, 511-22 (2007).
69. Hom, K. et al. Small molecule antivirulents targeting the iron-regulated heme oxygenase (HemO) of P. aeruginosa. J Med Chem 56, 2097-109 (2013).
70. Skaar, E. P., Gaspar, A. H. & Schneewind, O. IsdG and IsdI, heme-degrading enzymes in the cytoplasm of Staphylococcus aureus. J Biol Chem 279, 436-43 (2004).
71. Penwell, W. F., Arivett, B. A. & Actis, L. A. The Acinetobacter baumannii entA gene located outside the acinetobactin cluster is critical for siderophore production, iron acquisition and virulence. PLoS One 7, e36493 (2012).
72. Gaddy, J. A. et al. Role of Acinetobactin-mediated Iron Acquisition Functions in the Interaction of Acinetobacter baumannii ATCC 19606T with Human Lung Epithelial Cells, Galleria mellonella Caterpillars and Mice. Infect Immun 80, 1015-24 (2012).
73. Antunes, L. C., Imperi, F., Towner, K. J. & Visca, P. Genome-assisted identification of putative iron-utilization genes in Acinetobacter baumannii and their distribution among a genotypically diverse collection of clinical isolates. Res Microbiol 162, 279-84 (2010).
74. Turton, J. F., Gabriel, S. N., Valderrey, C., Kaufmann, M. E. & Pitt, T. L. Use of sequence-based typing and multiplex PCR to identify clonal lineages of outbreak strains of Acinetobacter baumannii. Clin Microbiol Infect 13, 807-15 (2007).
75. Diancourt, L., Passet, V., Nemec, A., Dijkshoorn, L. & Brisse, S. The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS One 5, e10034 (2010).
76. Gao, F. & Zhang, C. T. Ori-Finder: a web-based system for finding oriCs in unannotated bacterial genomes. BMC Bioinformatics 9, 79 (2008).
77. Delcher, A. L., Bratke, K. A., Powers, E. C. & Salzberg, S. L. Identifying bacterial genes and endosymbiont DNA with Glimmer. Bioinformatics 23, 673-9 (2007).
78. Srivastava, A., Singhal, N., Goel, M., Virdi, J. S. & Kumar, M. CBMAR: a comprehensive beta-lactamase molecular annotation resource. Database (Oxford) 2014, bau111 (2014).
79. Schattner, P., Brooks, A. N. & Lowe, T. M. The tRNAscan-SE, snoscan and snoGPS web servers for the detection of tRNAs and snoRNAs. Nucleic Acids Res 33, W686-9 (2005).
80. Lagesen, K. et al. RNAmmer: consistent and rapid annotation of ribosomal RNA genes. Nucleic Acids Res 35, 3100-8 (2007).
81. Altschul, S. F. et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25, 3389-402 (1997).
82. Chen, L., Xiong, Z., Sun, L., Yang, J. & Jin, Q. VFDB 2012 update: toward the genetic diversity and molecular evolution of bacterial virulence factors. Nucleic Acids Res 40, D641-5 (2012).
83. Ou, H. Y. et al. MobilomeFINDER: web-based tools for in silico and experimental discovery of bacterial genomic islands. Nucleic Acids Res 35, W97-W104 (2007).
84. Dhillon, B. K., Chiu, T. A., Laird, M. R., Langille, M. G. & Brinkman, F. S. IslandViewer update: Improved genomic island discovery and visualization. Nucleic Acids Res 41, W129-32 (2013).
85. Siguier, P., Perochon, J., Lestrade, L., Mahillon, J. & Chandler, M. ISfinder: the reference centre for bacterial insertion sequences. Nucleic Acids Res 34, D32-6 (2006).
86. Roberts, A. P. et al. Revised nomenclature for transposable genetic elements. Plasmid 60, 167-73 (2008).
87. Medema, M. H., Takano, E. & Breitling, R. Detecting sequence homology at the gene cluster level with MultiGeneBlast. Mol Biol Evol 30, 1218-23 (2013).
88. Shao, Y. et al. mGenomeSubtractor: a web-based tool for parallel in silico subtractive hybridization analysis of multiple bacterial genomes. Nucleic Acids Res 38, W194-200 (2010).
89. CLSI. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved Standard - Ninth Edition. M07-A9, (Clinical and Laboratory Standards Institute, Wayne, PA, 2012).